10 Best Performing Growth Stocks in 2025

2. Axsome Therapeutics, Inc. (NASDAQ:AXSM)

YTD-Performance: 36.03%

Number of Hedge Fund Holders: 44

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical company that develops and delivers therapies for central nervous system conditions with limited treatment options. It has two commercial products, Auvelity and Sunosi, and several products in development, including AXS-05 and AXS-07.

On March 6, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on the stock with a price target of $200. The analyst likes the company’s strategic developments and potential market advantages. Selvaraju mentioned the strategic developments including a settlement agreement regarding patent litigation over Sunosi. This can potentially lead to securing the market exclusivity until 2040. Moreover, Axsome Therapeutics, Inc. (NASDAQ:AXSM) progress with AXS-05 for Alzheimer ‘s-associated agitation, with positive feedback from the FDA indicates a clear path for submission of a supplemental New Drug Application. Selvaraju believes the potential approval and market introduction of AXS-05 could significantly enhance the company’s product portfolio and revenue streams. It is one of the best-performing growth stocks in 2025.